MedTrace Logo

BE.Amycon Registry UZ Leuven

NCT06998355 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2025-08-28

No results posted yet for this study

Summary

The goal of this observational study is to establish database with (limited) personal and health data of patients diagnosed with amyloidosis (any subtype) in order to get better insights on the disease presentation, disease evolution pattern, treatment plans and responses and survival.

Conditions

  • Amyloidosis

Interventions

OTHER

Registry

observational data collection

Sponsors & Collaborators

  • Vlaams Instituut voor Biotechnologie

    collaborator UNKNOWN

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2027-12-31
Completion
2028-06-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06998355 on ClinicalTrials.gov